{"id":207902,"date":"2025-06-27T08:40:12","date_gmt":"2025-06-27T08:40:12","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/207902\/"},"modified":"2025-06-27T08:40:12","modified_gmt":"2025-06-27T08:40:12","slug":"sanofi-va-vendre-son-usine-de-maisons-alfort-nouvelle-etape-de-la-restructuration-du-groupe-en-france","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/207902\/","title":{"rendered":"Sanofi va vendre son usine de Maisons-Alfort, nouvelle \u00e9tape de la restructuration du groupe en France"},"content":{"rendered":"<p>                         <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/fr\/wp-content\/uploads\/2025\/06\/fe785d5_upload-1-vfeoc17nckzg-rea-274235-019.jpg\" alt=\"Site de production pharmaceutique de Sanofi, \u00e0 Maisons-Alfort (Val-de-Marne), en\u00a0avril 2019.\"   width=\"664\" height=\"443\"\/>    Site de production pharmaceutique de Sanofi, \u00e0 Maisons-Alfort (Val-de-Marne), en\u00a0avril 2019.  XAVIER POPY\/REA                 <\/p>\n<p class=\"article__paragraph  \">Sanofi poursuit le m\u00e9nage dans ses sites fran\u00e7ais. Apr\u00e8s l\u2019annonce, au mois de mars, du <a href=\"https:\/\/www.lemonde.fr\/economie\/article\/2025\/03\/13\/chez-sanofi-la-vente-de-l-aspegic-fait-craindre-un-effet-domino_6579949_3234.html\" target=\"_blank\" rel=\"noopener\">projet de cession de son usine d\u2019Amilly (Loiret), qui fabrique notamment l\u2019Asp\u00e9gic et le Kardegic<\/a>, le laboratoire pharmaceutique s\u2019appr\u00eate \u00e0 c\u00e9der un autre de ses sites de production dans l\u2019Hexagone, l\u2019usine de Maisons-Alfort, situ\u00e9e dans le Val-de-Marne, qui emploie pr\u00e8s de 600\u00a0personnes.<\/p>\n<p class=\"article__paragraph  \">Annonc\u00e9 aux syndicats au d\u00e9but de la semaine du 23\u00a0juin, le projet de vente doit \u00eatre officialis\u00e9 aupr\u00e8s des salari\u00e9s mardi 1er\u00a0juillet, lors d\u2019une rencontre entre la direction et les repr\u00e9sentants du personnel. Sanofi doit y d\u00e9voiler le nom du futur acqu\u00e9reur de l\u2019usine, un fa\u00e7onnier d\u2019origine allemande. Le groupe envisage de conclure la vente au cours de l\u2019automne.<\/p>\n<p class=\"article__paragraph  \">Si l\u2019avenir du site inqui\u00e9tait d\u00e9j\u00e0 depuis plusieurs mois les salari\u00e9s, qui jugeaient, apr\u00e8s l\u2019annonce de la vente de l\u2019usine d\u2019Amilly, que Maisons-Alfort serait l\u2019un des prochains sur la liste, la d\u00e9cision n\u2019en a pas moins surpris. \u00ab\u00a0Jusqu\u2019\u00e0 maintenant, la direction nous disait qu\u2019elle r\u00e9fl\u00e9chissait \u00e0 une solution pour ce site, mais elle n\u2019avait jamais ouvertement indiqu\u00e9 qu\u2019une vente \u00e9tait privil\u00e9gi\u00e9e\u00a0\u00bb, d\u00e9plore Fabien Mallet, coordinateur CGT \u00e0 Sanofi.<\/p>\n<p class=\"reading-mode-only \"><strong>Il vous reste 79.06% de cet article \u00e0 lire. La suite est r\u00e9serv\u00e9e aux abonn\u00e9s.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"Site de production pharmaceutique de Sanofi, \u00e0 Maisons-Alfort (Val-de-Marne), en\u00a0avril 2019. XAVIER POPY\/REA Sanofi poursuit le m\u00e9nage dans&hellip;\n","protected":false},"author":2,"featured_media":207903,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[35,33,34,1011,27],"class_list":{"0":"post-207902","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-economie","8":"tag-business","9":"tag-economie","10":"tag-economy","11":"tag-fr","12":"tag-france"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/114754435869653828","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/207902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=207902"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/207902\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/207903"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=207902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=207902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=207902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}